Novo Nordisk | NVO - Ordinary Share Capital


Novo Nordisk reported DKK4.44B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
ANI Pharmaceuticals USD 21.73M 21.73M Jun/2025
Aurora Cannabis CAD 6.98B 907K Dec/2024
Bausch Health Companies USD 370.53M 59K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 332.38M 127.23M Sep/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
Drreddys Laboratories INR 832.57M 53K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Novartis USD 1.94B 23.4M Jun/2025
Novo Nordisk DKK 4.44B 0 Dec/2025
Novo Nordisk DKK 4.44B 3.99B Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 0 Sep/2025
Phibro Animal Health USD 4K 0 Sep/2024
Prestige Brands USD 48.08M 47.52M Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Zoetis USD 424.93M 16.54M Dec/2025